Viewing Study NCT01650259


Ignite Creation Date: 2025-12-24 @ 2:52 PM
Ignite Modification Date: 2025-12-26 @ 1:52 PM
Study NCT ID: NCT01650259
Status: COMPLETED
Last Update Posted: 2019-09-18
First Post: 2012-07-24
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Long-term Daily Use of Trazenta® Tablets in Patients With Type 2 Diabetes Mellitus
Sponsor: Boehringer Ingelheim
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: 1218.95
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View